Burkina Faso vs South Sudan: Population requiring preventive chemotherapy for schistosomiasis
Burkina Faso
4.46 million
in 2024
South Sudan
3.75 million
in 2024
Burkina Faso rank
19th
South Sudan rank
22nd
Population requiring preventive chemotherapy for schistosomiasis over time
- Burkina Faso
- South Sudan
How they compare
Burkina Faso currently reports 4.46 million against 3.75 million in South Sudan, a difference of 710,990.
That makes Burkina Faso's figure about 1.2 times South Sudan's.
The two have swapped places 3 times across 12 shared years of data; in 2013 it was South Sudan ahead.
Burkina Faso ranks 19th and South Sudan ranks 22nd of 52 countries.
Burkina Faso has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burkina Faso | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.63 million | 2.57 million | 2.05 million | Burkina Faso |
| 2020s | 3.48 million | 3.48 million | 2,934 | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Burkina Faso or South Sudan?
- Burkina Faso, at 4.46 million against 3.75 million in South Sudan as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Burkina Faso and South Sudan?
- 710,990, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and South Sudan?
- 12 years are reported by both, from 2013 to 2024.
- How do Burkina Faso and South Sudan rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Burkina Faso ranks 19th and South Sudan ranks 22nd of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.